Nantahala Capital Management LLC 13D and 13G filings for Evoke Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-03 4:47 pm Purchase | 2025-02-03 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management LLC | 254,639 15.990% | 254,639 (New Position) | Filing |